Term ends no later than Mar 12, 2034 · Medium confidence
20-year base term ends Mar 12, 2034
In force on USPTO's status record and by its fee record. A terminal disclaimer on file may shorten this term, possibly to a date already past; its reference document is unresolved, so the date above is an upper bound and no earlier date is guessed.
Mar 12, 2014
Mar 12, 2034
May 19, 2020
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is on file with no resolved reference, so no cap is applied and none is guessed. 1 of 3 maintenance fees is paid so far. Confidence: Medium. from the record
How we calculated this date
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Mar 12, 2014, when application 14/207,127, the earliest non-provisional in its chain, was filed (this one was filed Aug 23, 2018) | Mar 12, 2034 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer on file (approved), reference document not resolved | no cap applied, and none guessed | Medium confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | no later than Mar 12, 2034 | Medium confidence |
This family
| US 9,492,535 | In force Mar 2034 | Mar 2034 |
| US 10,086,068 | Lapsed on the fee record Oct 2026 | Oct 2026 |
| US 10,653,773 | this patent no later than Mar 2034 | no later than Mar 2034 |
| US 10,512,686 | In force Mar 2034 | Mar 2034 |
| US 12,016,917 | In force Jun 2034 | Jun 2034 |
| Application 18/736,943 | Pending not computed | not computed |
Assignments
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Sep 18, 2018 Reel 46904, frame 172 | Walser, Bryan; Raff, Howard V. | Aimmune Therapeutics, Inc. | Assignment of Assignor's Interest |
| Jan 4, 2019 Reel 47906, frame 433 | Aimmune Therapeutics, Inc. | Cortland Capital Market Services LLC | Security Interest |
| Oct 13, 2020 Reel 54064, frame 106 | Cortland Capital Market Services LLC | Aimmune Therapeutics, Inc. | Release of Security Interest in Patent Collateral |
| Feb 21, 2022 Reel 59057, frame 590 | Aimmune Therapeutics, Inc. | Société des Produits Nestlé S.A. | Assignment of Assignor's Interest |
| Aug 11, 2022 Reel 60781, frame 836 | Aimmune Therapeutics, Inc. | Societe des Produits Nestle S.A. | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
What's changing
A terminal disclaimer is on file (approved) and its reference document is not resolved. A disclaimer would cap the term earlier than Mar 12, 2034. We will not guess the cap.